ALDX
ALDX
NASDAQ · Biotechnology

Aldeyra Therapeutics Inc

$0.54
-0.02 (-4.16%)
As of Nov 7, 2:12 AM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +7,941.0% upside
Low Target $31.72
Average Target $43.18
High Target $59.84
Current Price $0.54
Current
$0.54
Target
$43.18
$31.72 $43.18 avg $59.84
Scenario Analysis
Bear Case
$31.72
5,806.9%
Low target
Base Case
$43.18
+7,941.0%
Avg target
Bull Case
$59.84
+11,043.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.93
-90.9% from high
52-Week Low
$0.53
+1.9% from low
50-Day SMA
$1.05
-48.9% vs SMA
200-Day SMA
$2.17
-75.3% vs SMA
RSI (14)
46.7
Neutral
Target vs 52W High
$43.18
+628.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.7%